Cas:24063-71-6 Isocurcumenol manufacturer & supplier

Chemical Name:Isocurcumenol

CAS.NO:24063-71-6

Synonyms:Isocurcumenol;9-Isopropylidene-2-methyl-6-methylene-11-oxatricyclo[6.2.1.0]undecan-8-ol;isocurcomenol;6H-3a,6-Epoxyazulen-6-ol, octahydro-3-methyl-8-methylene-5-(1-methylethylidene)-;(1S,2S,5S,8R)-9-Isopropylidene-2-methyl-6-methylene-11-oxa-tricyclo[6.2.1.01,5]undecan-8-ol;(3a,3aα,6α,8aβ)-5-isopropylidene-3-methyl-8-methylene-3a,6-epoxyperhydroazulen-6-ol;Isourecumenol

Molecular Formula:C₁₅H₂₂O₂

Molecular Weight:234.334

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:351.0±42.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.546

PSA:29.46000

Exact Mass:234.161987

LogP:3.46

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Isocurcumenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Isourecumenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Isourecumenol Use and application,isocurcomenol technical grade,usp/ep/jp grade.

Related News: The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). Isocurcumenol manufacturer The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). Isocurcumenol supplier The Covington inquiry is significant because Lilly’s handling of any employee allegations is likely to be considered by U.S. prosecutors as they weigh whether there are grounds to pursue criminal charges, seek civil action, or decline to bring a case at all, several legal experts said. Isocurcumenol vendor The Covington inquiry is significant because Lilly’s handling of any employee allegations is likely to be considered by U.S. prosecutors as they weigh whether there are grounds to pursue criminal charges, seek civil action, or decline to bring a case at all, several legal experts said. Isocurcumenol factory The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively).